Identifying Heart, Lung, and Blood Disease-Causing Variants
Page 2

The diseases that are included in this inquiry are early onset myocardial infarction, anthropometry, extremely low density lipoprotein, early onset ischemic stroke, extrelemy low or high blog pressure, chronic obstructive pulmonary diseases, cystic fibrosis, pulmonary hypertension, asthma, and acute lung injury.

The Identifying Heart, Lung, and Blood Disease-Causing Variants Program seeks to collaborate with population geneticists, epidemiologists, statistical geneticists, disease experts, and laboratory genomic experts to gain a more thorough and efficient understanding of the newly established exome variants associated with the complex diseases that are identified by the National Heart, Lung, and Blood Institute.

The agencies funding this program is set to administer a total of $1,515,000 per year to support the activities of the program in focus.

In order to be eligible to submit an application for this program you should be any of the following:

a) Higher Education Institutions such as Public/State Controlled Institutions of Higher Education and Private Institutions of Higher Education

b) Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions

c) Nonprofit organizations other than institutions of higher education

d) For-Profit Organizations such as Small Businesses

e) State Governments, County Governments, City or Township Governments, Special District Governments, Indian/Native American Tribal Governments (Federally Recognized), and Indian/Native American Tribal Governments (Other than Federally Recognized)

f) Independent School Districts, Public Housing Authorities/Indian Housing Authorities, Native American Tribal Organizations (other than Federally recognized tribal governments), Faith-based or Community-based Organizations, and Regional Organizations.

Identifying Heart, Lung, and Blood Disease-Causing Variants
  Back to Page 1

About The Author The TopGovernmentGrants Editorial Staff maintains one the most comprehensive Websites offering information on government grants and federal government programs. The staff also provides resources to other Websites with information on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Early-Stage Innovative Technology Development for Cancer Research Program
The National Institutes of Health has collaborated with the National Cancer Institute(NCI) in order to establish Early-Stage Innovative Technology Development for Cancer Research Program, wherein both agencies intend to solicit grant applications expressing intents to conduct funded exploratory research projects that concentrate on the inception and development unique, innovative technological advances that could potentially be utilized in the study of cancer.

---

Capacity Building Assistance to Improve Health in Tribal Populations Program
In keeping with all its existing programs and objectives, the Centers for Disease Control and Prevention has recently established a funding opportunity to promote the Capacity Building Assistance to Improve Health in Tribal Populations Program.

---

Behavioral Interventions to Address Multiple Chronic Health Conditions in Primary Care Program
The National Institutes of Health has recently established the Behavioral Interventions to Address Multiple Chronic Health Conditions in Primary Care Program wherein it intends to utilize common conceptual models in creating independent interventions that will contribute to the modification of health behaviors and the improvement of health outcomes in patients diagnosed with co-morbid chronic diseases and health conditions.

---

Basic Research on HIV Persistence Program
In keeping with this mission, the National Institutes of Health has recently constituted the establishment of the Basic Research on HIV Persistence Program in an attempt to increase our understanding of the persistence of HIV-1 infections in patients under highly active anti-retroviral therapy (HAART).

---